Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 26 03 2021
revised: 26 05 2021
accepted: 04 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 27 10 2021
Statut: epublish

Résumé

The pro-tumorigenic activity of fibroblast growth factor (FGF) 19 (FGF15 in its rodent orthologue) in hepatocellular carcinoma (HCC), as well as the unsolved problem that ischemia-reperfusion (IR) injury supposes in liver surgeries, are well known. However, it has been shown that FGF15 administration protects against liver damage and regenerative failure in liver transplantation (LT) from brain-dead donors without tumor signals, providing a benefit in avoiding IR injury. The protection provided by FGF15/19 is due to its anti-apoptotic and pro-regenerative properties, which make this molecule a potentially beneficial or harmful factor, depending on the disease. In the present review, we describe the preclinical models currently available to understand the signaling pathways responsible for the apparent controversial effects of FGF15/19 in the liver (to repair a damaged liver or to promote tumorigenesis). As well, we study the potential pharmacological use that has the activation or inhibition of FGF15/19 pathways depending on the disease to be treated. We also discuss whether FGF15/19 non-pro-tumorigenic variants, which have been developed for the treatment of liver diseases, might be promising approaches in the surgery of hepatic resections and LT using healthy livers and livers from extended-criteria donors.

Identifiants

pubmed: 34200439
pii: cells10061421
doi: 10.3390/cells10061421
pmc: PMC8228386
pii:
doi:

Substances chimiques

FGF19 protein, human 0
Fibroblast Growth Factors 62031-54-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : RTI2018-095114-B-I00
Organisme : Secretaria d'Universitats i Recerca
ID : 2017SGR-551
Organisme : COST action Programs
ID : CA17103 (DARTER)
Organisme : COMULIS
ID : CA17121
Organisme : PROEURO-DILI-NETWORK
ID : CA17112
Organisme : TUMIEE
ID : CA17126

Références

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G440-5
pubmed: 20093562
Protein Cell. 2021 May;12(5):411-425
pubmed: 33252713
Expert Opin Ther Targets. 2015 May;19(5):675-85
pubmed: 25547779
Science. 2012 Sep 7;337(6099):1231-5
pubmed: 22837387
Lancet Oncol. 2015 Nov;16(15):1473-1482
pubmed: 26482279
Nature. 2007 Mar 8;446(7132):153-8
pubmed: 17344846
Cancer Res. 2013 Oct 1;73(19):5926-35
pubmed: 23943801
Oncogene. 2010 Sep 9;29(36):4989-5005
pubmed: 20639898
J Biol Chem. 2007 Sep 14;282(37):26687-26695
pubmed: 17623664
Cell Death Dis. 2015 Jun 04;6:e1777
pubmed: 26043077
Lancet. 2016 Mar 5;387(10022):968-977
pubmed: 26703889
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13839-44
pubmed: 23918388
Cold Spring Harb Symp Quant Biol. 2011;76:139-44
pubmed: 21813638
Hepatology. 2012 Dec;56(6):2336-43
pubmed: 22711662
Liver Transpl. 2001 May;7(5):409-14
pubmed: 11349260
Hepatology. 2012 Dec;56(6):2344-52
pubmed: 22730081
J Biomed Biotechnol. 2011;2011:567305
pubmed: 22007144
J Lipid Res. 2007 Dec;48(12):2664-72
pubmed: 17720959
Dev Cell. 2019 Feb 25;48(4):460-474.e9
pubmed: 30745141
J Surg Res. 1995 Mar;58(3):267-74
pubmed: 7885023
Inflamm Bowel Dis. 2011 Jun;17(6):1322-7
pubmed: 21058331
Mol Carcinog. 2009 Jun;48(6):553-62
pubmed: 19009564
Comp Hepatol. 2005 Dec 23;4:10
pubmed: 16375767
Clin Sci (Lond). 2015 Aug;129(4):345-62
pubmed: 26014222
Clin Cancer Res. 2008 Oct 1;14(19):6146-53
pubmed: 18829493
Lipids. 1989 Sep;24(9):759-64
pubmed: 2586232
J Hepatol. 2016 Mar;64(3):674-81
pubmed: 26529078
Gut. 2015 Sep;64(9):1444-53
pubmed: 25416068
Eur J Pharmacol. 2018 Sep 15;835:1-10
pubmed: 30075219
Toxicol In Vitro. 2013 Mar;27(2):964-77
pubmed: 23274766
Am J Surg. 2005 Jul;190(1):75-86
pubmed: 15972177
World J Gastroenterol. 2017 Oct 7;23(37):6833-6844
pubmed: 29085226
J Hepatol. 2020 Nov;73(5):1131-1143
pubmed: 32422221
EMBO Mol Med. 2010 Aug;2(8):294-305
pubmed: 20652897
PLoS One. 2012;7(6):e39540
pubmed: 22761819
N Engl J Med. 2020 Oct 22;383(17):1613-1623
pubmed: 33085860
Am J Pathol. 2002 Jun;160(6):2295-307
pubmed: 12057932
Genes Dev. 2007 Apr 15;21(8):886-97
pubmed: 17437995
Clin Exp Gastroenterol. 2008;1:19-47
pubmed: 21677822
Clin Cancer Res. 2012 Jul 15;18(14):3780-90
pubmed: 22648271
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:203-12
pubmed: 21199532
Liver Transpl. 2020 Dec;26(12):1603-1617
pubmed: 32750732
Carcinogenesis. 2014 Oct;35(10):2331-8
pubmed: 25031272
J Clin Oncol. 2013 Oct 1;31(28):3517-24
pubmed: 23980084
Trends Genet. 2009 Jan;25(1):30-8
pubmed: 19054589
J Lipid Res. 2009 Sep;50(9):1721-34
pubmed: 19417220
Cancer Res. 1996 Apr 1;56(7):1480-3
pubmed: 8603388
Clin Cancer Res. 2009 Mar 15;15(6):2058-66
pubmed: 19240166
Endocr Rev. 2002 Aug;23(4):443-63
pubmed: 12202460
Exp Cell Res. 1999 Apr 10;248(1):203-13
pubmed: 10094827
Biochem J. 2018 Sep 25;475(18):2985-2996
pubmed: 30127091
FASEB J. 2009 Oct;23(10):3516-25
pubmed: 19546304
Pharmacol Rev. 2020 Apr;72(2):486-526
pubmed: 32198236
Hepatology. 2006 Feb;43(2 Suppl 1):S45-53
pubmed: 16447274
Biochim Biophys Acta. 2015 Feb;1849(2):196-200
pubmed: 24878541
Gut. 2013 Jun;62(6):899-910
pubmed: 23292666
Mol Cancer Ther. 2011 Nov;10(11):2157-67
pubmed: 21885862
PLoS One. 2013 May 16;8(5):e63695
pubmed: 23696849
Am J Pathol. 2002 Aug;161(2):587-601
pubmed: 12163383
Nat Commun. 2020 Nov 24;11(1):5969
pubmed: 33235221
PLoS One. 2012;7(5):e36713
pubmed: 22615798
J Hepatol. 2019 Mar;70(3):483-493
pubmed: 30414864
J Surg Res. 2001 Apr;96(2):289-95
pubmed: 11266286
J Hepatol. 2013 Sep;59(3):583-94
pubmed: 23567086
Oncogene. 2008 Jan 3;27(1):85-97
pubmed: 17599042
Mol Cancer. 2012 Mar 23;11:14
pubmed: 22439738
J Intern Med. 2006 Dec;260(6):530-6
pubmed: 17116003
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375200
J Mol Med (Berl). 2019 Sep;97(9):1299-1314
pubmed: 31254006
Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):226-9
pubmed: 23434440
Int J Mol Sci. 2019 Jan 29;20(3):
pubmed: 30700007
World J Gastrointest Pathophysiol. 2017 May 15;8(2):11-26
pubmed: 28573064
Cells. 2019 Dec 14;8(12):
pubmed: 31847428
Cancer Discov. 2019 Dec;9(12):1696-1707
pubmed: 31575541
Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G893-902
pubmed: 24699334
Physiol Res. 2011;60(4):627-36
pubmed: 21574752
Toxicology. 2001 Jan 2;156(2-3):129-38
pubmed: 11164615
J Cell Physiol. 2007 Nov;213(2):286-300
pubmed: 17559071
Pharmacol Ther. 2017 Nov;179:171-187
pubmed: 28564583
Carcinogenesis. 2007 Feb;28(2):488-96
pubmed: 16990345
Annu Rev Biochem. 1999;68:913-63
pubmed: 10872469
Hepatology. 2020 Apr;71(4):1421-1436
pubmed: 31469186
Adv Exp Med Biol. 2012;728:183-94
pubmed: 22396170
Endocrinology. 2004 Jun;145(6):2594-603
pubmed: 14976145
Cancer Res. 2008 Jul 1;68(13):5086-95
pubmed: 18593907
J Clin Transl Res. 2018 May 28;4(1):1-46
pubmed: 30761355
Biol Pharm Bull. 2015;38(7):986-91
pubmed: 26133708
J Toxicol Sci. 2016;41(4):561-72
pubmed: 27452039
PLoS One. 2014 May 19;9(5):e97426
pubmed: 24841254
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128
pubmed: 29018272
J Cell Sci. 2014 Feb 15;127(Pt 4):709-17
pubmed: 24532814
Nucleic Acids Res. 2004 Feb 11;32(3):1113-21
pubmed: 14960721
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Oncotarget. 2015;6(12):9686-700
pubmed: 25991671
Nat Cell Biol. 2001 Jul;3(7):650-7
pubmed: 11433297
BMC Cancer. 2012 Feb 06;12:56
pubmed: 22309595
Mol Endocrinol. 2009 Feb;23(2):137-45
pubmed: 19056864
Clin Exp Metastasis. 2013 Jun;30(5):681-93
pubmed: 23385555
J Clin Oncol. 2009 Mar 20;27(9):1485-91
pubmed: 19224838
Cell Metab. 2011 Jun 8;13(6):729-38
pubmed: 21641554
Int J Cancer. 2015 May 15;136(10):2469-75
pubmed: 25346390
Oncology. 2011;81(5-6):372-80
pubmed: 22269894
Expert Rev Anticancer Ther. 2019 Feb;19(2):177-189
pubmed: 30575405
BMC Med. 2017 Feb 16;15(1):34
pubmed: 28202005
Trends Mol Med. 2011 May;17(5):283-92
pubmed: 21367659
J Lipid Res. 2009 Oct;50(10):1955-66
pubmed: 19346330
Cancer Discov. 2012 Dec;2(12):1118-33
pubmed: 23002168
Hepatology. 2018 Jun;67(6):2150-2166
pubmed: 29159825
Gut. 2017 Oct;66(10):1818-1828
pubmed: 28119353
J Inherit Metab Dis. 2011 Jun;34(3):593-604
pubmed: 21229319
Int J Cancer. 2017 Jun 1;140(11):2545-2556
pubmed: 28187526
J Exp Clin Cancer Res. 2019 May 29;38(1):228
pubmed: 31142342
Drugs. 2019 Apr;79(6):665-674
pubmed: 30993651
Hepatol Commun. 2017 Oct 16;1(10):1024-1042
pubmed: 29404440
J Clin Invest. 1986 Oct;78(4):1064-71
pubmed: 3760182
Transl Res. 2014 Apr;163(4):352-62
pubmed: 24495569
Gastroenterology. 2021 Jan;160(1):219-231.e1
pubmed: 32781086
Nat Med. 2006 Nov;12(11):1253-5
pubmed: 17072310
Ann Gastroenterol. 2018 Sep-Oct;31(5):613-620
pubmed: 30174399
Cancer Cell. 2017 May 8;31(5):669-684.e7
pubmed: 28486106
Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58
pubmed: 20628345
Gut. 2015 May;64(5):800-12
pubmed: 24973316
Curr Pharm Des. 2014;20(17):2881-98
pubmed: 23944363
J Biol Chem. 2004 Nov 26;279(48):50004-11
pubmed: 15377668
J Biol Chem. 2010 Sep 24;285(39):30069-78
pubmed: 20657013
Curr Mol Med. 2014;14(6):703-711
pubmed: 25056539
Cancer Res. 2012 Nov 15;72(22):5767-77
pubmed: 22971346
Hepatology. 2018 Nov;68(5):1961-1976
pubmed: 29672888
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15786-91
pubmed: 20798051
Cancer Sci. 2015 Oct;106(10):1278-87
pubmed: 26183471
Cell Mol Life Sci. 2008 Nov;65(23):3809-21
pubmed: 18791849
Cells. 2019 Jun 04;8(6):
pubmed: 31167419
Gastroenterology. 2013 Mar;144(3):512-27
pubmed: 23313965
Science. 2006 Apr 14;312(5771):233-6
pubmed: 16614213
World J Gastroenterol. 2006 Jun 28;12(24):3835-40
pubmed: 16804967
J Physiol Biochem. 2018 May;74(2):247-260
pubmed: 29468415
J Clin Oncol. 2020 Dec 20;38(36):4317-4345
pubmed: 33197225
PLoS One. 2016 Feb 10;11(2):e0148815
pubmed: 26863224
J Lipid Res. 2009 Dec;50(12):2340-57
pubmed: 19498215
Cell Signal. 2006 Jun;18(6):783-94
pubmed: 16109476
Int J Mol Sci. 2019 Aug 19;20(16):
pubmed: 31430957
Science. 2011 Mar 25;331(6024):1621-4
pubmed: 21436455
Liver Transpl. 2019 May;25(5):771-786
pubmed: 30740859
Gan. 1984 Jan;75(1):29-35
pubmed: 6724225
Carcinogenesis. 1994 Jul;15(7):1459-62
pubmed: 8033325
J Bone Miner Res. 2012 May;27(5):1004-17
pubmed: 22307978
J Biol Chem. 2012 Nov 30;287(49):41334-41
pubmed: 23038264
Hepatology. 2012 Dec;56(6):2404-11
pubmed: 22753116
Nat Commun. 2015 Feb 19;6:6239
pubmed: 25695629
Cancer Metab. 2013 Nov 25;1(1):21
pubmed: 24279986
J Hepatol. 2009 Jan;50(1):118-27
pubmed: 19008009
Histol Histopathol. 2015 Jan;30(1):13-31
pubmed: 25053532
Int J Mol Sci. 2020 Nov 27;21(23):
pubmed: 33261172
Dig Liver Dis. 2004 Jun;36(6):398-405
pubmed: 15248380
Biochim Biophys Acta. 2011 Aug;1812(8):888-92
pubmed: 21167938
Gastroenterology. 2012 Feb;142(2):355-65.e1-4
pubmed: 22057115

Auteurs

Albert Caballeria-Casals (A)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Marc Micó-Carnero (M)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Carlos Rojano-Alfonso (C)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Cristina Maroto-Serrat (C)

Aplicacions i Muntatge Torelló SL (AMT), 08570 Torelló, Spain.

Araní Casillas-Ramírez (A)

Hospital Regional de Alta Especialidad de Ciudad Victoria "Bicentenario 2010", Ciudad Victoria 87087, Mexico.
Facultad de Medicina e Ingeniería en Sistemas Computacionales de Matamoros, Universidad Autónoma de Tamaulipas, Matamoros 87300, Mexico.

Ana I Álvarez-Mercado (AI)

Departamento de Bioquímica y Biología Molecular II, Escuela de Farmacia, Universidad de Granada, 18071 Granada, Spain.
Institute of Nutrition and Food Technology "José Mataix", Center of Biomedical Research, University of Granada, 18016 Armilla, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Complejo Hospitalario Universitario de Granada, 18014 Granada, Spain.

Jordi Gracia-Sancho (J)

Liver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Laboratory IDIBAPS, 03036 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.

Carmen Peralta (C)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH